help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 2, 2009
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-0762
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
94/8/2751    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Ceriello, A.
Right arrow Articles by Giugliano, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ceriello, A.
Right arrow Articles by Giugliano, D.

Submitted on April 7, 2009
Accepted on May 26, 2009

Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes

Antonio Ceriello MD*, Katherine Esposito MD, Michael Ihnat PhD, Jessica Thorpe BS, and Dario Giugliano MD

Centre of Excellence in Diabetes and Endocrinology, University Hospital of Coventry and Warwickshire, Warwick Medical School, University of Warwick, Coventry, U.K.; Division of Metabolic Diseases, Center of Excellence for Cardiovascular Diseases, 2ndUniversity of Naples SUN, Italy; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, U.S.A.

* To whom correspondence should be addressed. E-mail: antonio.ceriello{at}warwick.ac.uk.

Objective: To investigate the effect of different periods of hyperglycemia on the reversal of endothelial dysfunction by glucose normalization and antioxidant therapy.

Research Design and Methods: Ten healthy subjects and three subgroups of ten type 1 diabetic subjects were enrolled as follows: 1) patients within one month of diagnosis; 2) patients between 4.5 to 5.2 years from diagnosis and with HbA1c levels ≤ 7% since diagnosis; 3) patients between 4.8 to 5.4 years from diagnosis and with HbA1c levels >7% since diagnosis.

Each patient participated in three experiments: a) 24 hour insulin treatment, achieving a near-normalization of glycemia, together with the addition of the antioxidant vitamin C during the last 12 hours; b) 24 hours vitamin C treatment with insulin treatment for the last 12 hours; c) treatment with both vitamin C and insulin for 24 hours.

Results: Endothelial function, as measured by flow-mediated vasodilation (FMD) of the brachial artery and levels of nitrotyrosine, an oxidative stress marker, were normalized by each treatment in subgroups 1 and 2. In the third subgroup, neither glucose normalization or vitamin C treatment alone was able to normalize endothelial dysfunction or oxidative stress. Combining insulin and vitamin C, however, normalized endothelial dysfunction and nitrotyrosine.

Conclusions: This study suggests that long-lasting hyperglycemia in type 1 diabetic patients induces long-term alterations in endothelial cells, which may contribute to endothelial dysfunction and is interrupted only by both glucose and oxidative stress normalization.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society